Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.
Details
Serval ID
serval:BIB_6A6D79CC6A49
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.
Journal
The Journal of clinical investigation
ISSN
1558-8238 (Electronic)
ISSN-L
0021-9738
Publication state
Published
Issued date
02/10/2017
Peer-reviewed
Oui
Volume
127
Number
10
Pages
3877-3896
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Primary open-angle glaucoma (POAG) is often caused by elevated intraocular pressure (IOP), which arises due to increased resistance to aqueous humor outflow (AHO). Aqueous humor flows through Schlemm's canal (SC), a lymphatic-like vessel encircling the cornea, and via intercellular spaces of ciliary muscle cells. However, the mechanisms underlying increased AHO resistance are poorly understood. Here, we demonstrate that signaling between angiopoietin (Angpt) and the Angpt receptor Tie2, which is critical for SC formation, is also indispensable for maintaining SC integrity during adulthood. Deletion of Angpt1/Angpt2 or Tie2 in adult mice severely impaired SC integrity and transcytosis, leading to elevated IOP, retinal neuron damage, and impairment of retinal ganglion cell function, all hallmarks of POAG in humans. We found that SC integrity is maintained by interconnected and coordinated functions of Angpt-Tie2 signaling, AHO, and Prox1 activity. These functions diminish in the SC during aging, leading to impaired integrity and transcytosis. Intriguingly, Tie2 reactivation using a Tie2 agonistic antibody rescued the POAG phenotype in Angpt1/Angpt2-deficient mice and rejuvenated the SC in aged mice. These results indicate that the Angpt-Tie2 system is essential for SC integrity. The impairment of this system underlies POAG-associated pathogenesis, supporting the possibility that Tie2 agonists could be a therapeutic option for glaucoma.
Keywords
Angiopoietin-1/genetics, Angiopoietin-1/metabolism, Angiopoietin-2/genetics, Angiopoietin-2/metabolism, Animals, Cornea/blood supply, Cornea/metabolism, Cornea/pathology, Female, Glaucoma, Open-Angle/genetics, Glaucoma, Open-Angle/metabolism, Glaucoma, Open-Angle/pathology, Homeodomain Proteins/genetics, Homeodomain Proteins/metabolism, Humans, Male, Mice, Mice, Transgenic, Signal Transduction, Transcytosis/genetics, Tumor Suppressor Proteins/genetics, Tumor Suppressor Proteins/metabolism
Pubmed
Web of science
Open Access
Yes
Create date
10/03/2022 8:53
Last modification date
11/03/2022 6:33